Needle-free injection technology in swine: Progress toward vaccine efficacy and pork quality

Journal of Swine Health and Production

Volumn 16, Issue 5, 2008, Pages 254-261

  Chase, Christopher C L ^a   Daniels, C Scanlon ^b   Garcia, Roberto ^b   Milward, Frank ^b   Nation, Tiffany ^b  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Needle free; Pork quality; Swine; Transdermal; Vaccines

Indexed keywords

BACTERIA (MICROORGANISMS); SUIDAE;

EID: 52149086314     PISSN: 1537209X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Daniels CS. Needleless injections-good, bad, or ugly? Proc ISU Swine Dis Conf. 2005;28-30.
2. Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov. 2006;5:543-548.
3. Mitragotri S. Immunization without needles. Nat Rev Immunol. 2005;5:905-916.
4. Willson P. Needle free immunization. Pig Progress. 2004;26-27.
5. Baizer L, Lacey C, Hayes J, D'Antono L. Needle-free injectors: New technologies. The Drug Delivery Companies Report. 2001/02:51-54. Available at: www.drugdeliveryreport.com/cgi-bin/article_archive.cgi. Accessed 7 July 2008.
6. Sarno MJ, Blasé E, Galindo N, Ramierez R, Schirmer CL, Trujillo-Juarez DF. Clinical immunogenicity of measles, mumps and rubella vaccine delivered by the Injex jet injector: comparison with standard syringe injection. Ped lnf Dis J. 2000;19:839-842.
7. Stout RR, Gutierrez MJ, Roffman M, Marcos J, Sanchez R, Macias M, Quiroz R, Taylor D, Mckenzie B, Restrepo E, Pinera I, Craig-Rodriguez A, Restrepo M, Turner P, Richardson R, Baizer L, Walker M, Walker E. Subcutaneous injections with a single-use, pre-filled, disposable needle-free injection device or needle & syringe: comparative evaluation of efficacy & acceprability. Drug Delivery Tech. 2004;4:2-6.
8. Pork.org. Pork Quality Assurance Plus. 2008. Available at http://www.pork.org/Producers/PQAP.aspx. Accessed 12 June 2008.
9. Gergen L, Eddy B, Menassa K, McGregor C, Wasmoen T. Intramuscular and intradermal vaccination of swine for swine influenza virus and Mycoplasma hyopneumoniae using a needle-free device. Proc Leman Swine Conf. 2002;29(suppl37).
10. Gergen L, Eddy B, McCalmon P, Loskutov A, Wasmoen T. Needle-free vaccination for Mycophsma hyopneumoniae and swine influenza virus. Proc IPVS. 2002;288.
11. Jones GF, Rapp-Gabrielson V, Wilke R, Thacker EL, Thacker BJ, Gergen L, Sweeney D, Wasmoen T. Intradermal vaccination for Mycoplasma hyopneumoniae. J Swine Health Prod. 2005;13:19-27.
12. Rapp-Gabrielson VJ, Gergen LR, Eddy BA, Junker DE, Weston CQ, Fleck RW, Wasmoen TL. Efficacy of intradermal vaccination against challenge of swine with a heterologous H3N2 swine influenza virus. Proc Leman Swine Conf. 2003;30:25.
13. Schramm-Baxter J, Mitragotri S. Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power. J Control Release. 2004;97:527-535.
14. Hafer AL, Langley RL, Morrow WEM, Tulis JJ. Occupational hazards reported by swine veterinarians in the United States. Swine Health Prod. 1996;4:128-141.
15. Reis EC, Jacobson RM, Tarbell S, Weniger BG. Taking the sting out of shots: control of vaccination-associated pain and adverse reactions. Pediatr Ann. 1998;27:375-386.
16. Hingson RA, Davis HS, Rosen M. The historical development of jet injection and envisioned uses in mass immunization and mass therapy based upon two decades experience. Mil Med. 1963;128:516-524.
17. Anwer K, Earle KA, Shi M, Wang J, Mumper RJ, Proctor B, Jansa K, Ledebut HC, Davis S, Eaglstein W, Rolland AP. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharm Res. 1999:16:889-895.
18. Anonymous. Minimum effective dose of Porcilis PRRS. Available at http://www.porcilis-prrs.com/efficacy-ininimuin-dose.asp#table_l. Accessed 8 July 2008.
19. Borghetti P, De Angelis E, Miduri F, Gozio S, Blanchaert A, Alborali LG, Cordiioli P, Lombardi G, Quintavalla C, Guazzetti S, Martelli P Intradermal and intramuscular porcine reproductive and respiratory syndrome (PRRS) vaccination in piglets: changes of peripheral lymphocyte subpopulations. Proc Int Symp Emerging Re-emerging Pig Dis. 2003;77-78.
20. Rosales E, Mendoza S, Martens M, Quintero V, Ramirez C, Luna E, Vargas A, Reynoso M. Use of novel intradermal needle-free system: A field study comparing it with conventional intramuscular injection for administration of Aujeszky's disease vaccination (Porcilis® Begonia). Proc IPVS. 2006;2:157.
21. Gozio S, Ferrari L, Borghetti P, De Angelis E, Smets J, Blanchaert A, Martelli P. Specific humoral and cell-mediated immune response in pigs vaccinated intradermally (IDAL®) against Aujeszky's disease. Proc IPVS. 2006;2:152.
22. Charreyre C, Milward F, Nordgren R, Royer G. Demonstration of efficacy in pigs of Mycoplasma hyopneumoniae experimental vaccines by an innovative needle-free route. Proc AASV. Toronto, Ontario, Canada. 2005;113-115.
23. Royer G, Charreyre C, Milward F. Efficacy and safety of needle-free transdermal delivery of a novel Mycoplasma hyopneumoniae bacterin. Proc AASV. Kansas City, Missouri. 2006;239-241.
24. Thacker EL, Nilubol D, Evans R. Evaluation of a new transdermal Mycoplasma hyopneumoniae bacterin to control mycoplasmal pneumonia in pigs experimentally co-infected with PRRSV and Mycoplasma hyopneumoniae. Proc AASV. Orlando, Florida. 2007;135-138.
25. Babiuk S, Baca-Estrada ME, Foldvari M, Baizer L, Stout R, Storms M, Rabussay D, Widera G, Babiuk L. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther. 2003;8:992-998.
26. Wesley RD, Lager KM. Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus. Am J Vet Res. 2005;66:1943-1947.
27. Apley M, Thacker B. Determination of the phatmacokinetics of procaine penicillin in swine administered by intramuscular injection and with a needleless injection device. National Pork Board. Pork Checkoff. Research Abstract. 2003. Available at: http://www.pork.org/pork-science/research/ documents/02136-apley. abs.92603.pdf. Accessed 3 July 2008.
28. Senn MK, Bradford JR, Cook DL, Loskutov A. Comparison of pharmacokinetic parameters for Excenel RTU when injected by needle or Felton Pulse 250 needle-free injector. Proc AASV. Des Moines, Iowa. 2004;263-265.
29. Houser TA, Sebranek JG, Baas TJ, Thacker BJ, Nilubol D, Thacker EL. Feasibility of Transdermal, Needleless Injections for Prevention of Pork Carcass Defects. 2002. Available at: http://www. ipic.iastate.edu/reports/ 02swinereports/asl-1814.pdf. Accessed 3 July 2008.
30. Paquin G, Achacha M, Toburen T. The first effective transdermal, needle-free injections in Canada. Proc AASV. Toronto, Ontario, Canada. 2005;75.
31. Jolie R, Hoover T. Short-term efficacy study with Respisure-One® administered with a needle-free device. Proc Leman Swine Conf. 2004;31(suppl57).
32. Thacker B, Kruse F, Loskutoc A. Safety evaluarion of a modified live pseudorabies virus vaccine administered using a needle-free transdermal injection device. Proc AASV. Orlando, Florida. 2003;87-88.
33. Rosales E, Martens M, Vargas A, Torres S, Flores R, Flores E, Quijano M. A comparison of the efficacy of conventional and needle-free adminisrration of Porcilis® APP as assessed by ELISA concentrations of antibody concentration to Apx I, Apx II, Apx III and OMP. Proc IPVS. 2006;2:247.
34. Almond GW, Roberts JD. Assessment of a needleless injection device for iron dextran administration to piglets. Proc IPVS. 2004;618.
35. Diggle L, Deeks JJ, Pollatd AJ. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. Brit Med J. 2006;333:571-574.
36. Baizer L, Hayes J, Lacey C, D'Antonio L, Mathews M. Needle-free injectors: advantages, current technologies, and future innovations. Pharm Manu Pack Resour. 2002;Spring:96-100.
37. Evans A. Intra-dermal vaccination series. Part 2. Original engineering solution. Pig Progress. 2006;22:30.
38. Grosenbaugh DA, Leard T, Pardo MC. Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously. Vet Ther. 2004;5:258-262.
39. Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gotse GJ, Newman FK, Yu O, Weniger BG; Vaccine Safety Datalink Study Group. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine. 2001;19:4703-4709.
40. Van Drunen Littel-van den Hurk S. Rationale and perspectives on the success of vaccination against bovine hetpesvirus 1. Vet Microbiol. 2006;113:275-282.
41. Aguiar JC, Hedstrom RC, Rogers WO, Charoenvit Y, Sacci JB, Lanar DE, Majam VF, Stout RR, Hoffman SL. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine. 2001;20:275-280.
42. + type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci USA. 2001;98:10817-10822.
43. Williams J, Fox-Leyva L, Christensen C, Fisher D, Schlicting E, Snowball M, Negus S, Mayers J, Kollet R, Stout R. Hepatitis A vaccine administtation: comparison between jet-injector and needle injection. Vaccine. 2000;18:1939-1943.
44. Parent du Châtelet I, Lang J, Schlumberger M, Vidor E, Soula G, Genet A, Standaert SM, Saliou P. Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Vaccine. 1997;15:449-458.
45. Clark ML, Reinhart H, Miller MC III, Wilson R. Polyvalent influenza vaccine: comparison of jet injection with intradermal and subcutaneous syringe methods of administration. J Lab Clin Med. 1965;66:34-41.
46. Davies JW, Simon WR. Antibody response to influenza immunization by jet injection. Can J Pub Health. 1969;60:104-108.
47. Hsu CY, Huang LM, Lee CY, Lin TY, Lee PI, Chen JM. Local massage after vaccination enhances the immunogenicity of diphtheria-tetanus-pertussis vaccine. J Ped Inf Dis. 1995;14:567-572.
48. Cui Z, Baizer L, Mumper RJ. lntradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. J Biotechnol. 2003;102:102-115.
49. Bautista EM, Gregg D, Golde WT Characterization and functional analysis of skin-derived dendritic cells from swine without a requirement for in vitro propagation. Vet Immunol Immunopathol. 2002;88:131-148.
50. Bautista EM, Ferman GS, Gregg D, Brumm MC, Grubman MJ, Golde WT. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol. 2005;79:4838-4847.
51. Evans A. Intra-dermal vaccination series: Part 3. Skin immune system. Pig Progress. 2006:22:24-25.
52. Jamin A, Gorin S, Le Potier MF, Kuntz-Simon G. Characterization of conventional and plasmacytoid dendritic cells in swine secondary lymphoid organs and blood. Vet Immunol Immunopathol. 2006;114:224-237.
53. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 2003;19:47-57.
54. Bancheteau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
55. Ludewig B, Ehl S, Karrer U. Dendritic cells efficiently induce protective antiviral immunity. J Virol. 1998;72:3812-3818.
56. Gramzinski RA, Maris DC, Doolan D, Charoenvit Y, Obaldia N, Rossan R, Sedegah M, Wang R, Hobart P, Margalith M, Hoffman S. Malaria DNA vaccines in Aotus monkeys. Vaccine. 1997;15:913-915.
57. Gramzinski RA, Millan CL, Obaldia N, Hoffman SL, Davis HL. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol Med. 1998;4:109-118.
58. Lodmell DL, Ray NB, Ulrich JT, Ewalt LC. DNA vaccination of mice against rabies virus: effects of the rout of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine. 2000;18:1059-1066.